This was the stock's second consecutive day of gains.
Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic ...
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
Buying $100 In VRTX: If an investor had bought $100 of VRTX stock 5 years ago, it would be worth $253.80 today based on a ...
10h
Zacks.com on MSNWhy the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained TodayVertex Pharmaceuticals (VRTX) concluded the recent trading session at $502.92, signifying a +1.51% move from its prior day's close.
Vertex Minerals Limited (ASX:VTX) (OTCMKTS:VTXXF) is pleased to announce the purchase of an Epiroc Boomer TD1 development and production rig to b ...
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a ...
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...
Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...
"If we do our jobs right, and you come back a year from now, this place is going to be a buzzing hive" -- Vertex Executive ...
The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results